Literature DB >> 2398631

Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophy.

J Asano1, S Tomatsu, K Sukegawa, S Yamaguchi, Y Ikedo, R Minami, M Iida, M Nishimura, M Nakagawa, M Ohshiro.   

Abstract

Thirty-eight unrelated Japanese patients with Duchenne and Becker muscular dystrophy (DMD and BMD) have been investigated with the DMD cDNA probes. The 14-kb DMD cDNA was subdivided into 6 subclones and HindIII-digested DNAs were analyzed by Southern blotting. Out of 38 unrelated patients, 14 showed a deletion of one or several of the exon-containing HindIII fragments (36.8%). These corresponded to 50% (9/18) of BMD patients and 25% (5/20) of DMD patients, and the position and extent of deletions were mapped and proved to be more heterogeneous in DMD than in BMD. Both ends of deletions detected in probe 1-2a were common to all six BMD patients without the maintenance of reading frame of messenger RNA, and 5' ends of deletions in probe 5b-7 were also common but maintained in frame in three BMD patients. The phenotypic-specific deletion in Japanese BMD patients has existed in the 5' end of the DMD gene, although its apparently similar deletion produced a wide range of clinical courses (BMD phenotype). There was no tight correlation between clinical severity and presence or absence of deletion in DMD or BMD.

Entities:  

Mesh:

Year:  1990        PMID: 2398631     DOI: 10.1007/BF01876461

Source DB:  PubMed          Journal:  Jinrui Idengaku Zasshi        ISSN: 0021-5074


  2 in total

1.  Molecular study of Duchenne and Becker muscular dystrophies in Japanese.

Authors:  H Tsukamoto; K Inui; H Fukushima; T Nishigaki; M Taniike; J Tanaka; S Okada
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Duplication detection in Japanese Duchenne muscular dystrophy patients and identification of carriers with partial gene deletions using pulsed-field gel electrophoresis.

Authors:  M Kodaira; K Hiyama; T Karakawa; H Kameo; C Satoh
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.